Medtronic Inc
(MDT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2015 | 04-2014 | 04-2013 | 04-2012 | 04-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,675,000 | 3,065,000 | 3,467,000 | 3,617,000 | 3,096,000 |
| Depreciation Amortization | 1,382,000 | 858,000 | 923,000 | 918,000 | 975,000 |
| Income taxes - deferred | -926,000 | -207,000 | -7,000 | 14,000 | 153,000 |
| Accounts receivable | -413,000 | -70,000 | 1,000 | -252,000 | -342,000 |
| Other Working Capital | 797,000 | 218,000 | 360,000 | 18,000 | -1,012,000 |
| Other Operating Activity | 1,387,000 | 1,095,000 | 198,000 | 155,000 | 871,000 |
| Operating Cash Flow | $4,902,000 | $4,959,000 | $4,942,000 | $4,470,000 | $3,741,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,692,000 | -2,784,000 | -1,810,000 | -1,987,000 | 275,000 |
| PPE Investments | -571,000 | -396,000 | -457,000 | -484,000 | -501,000 |
| Net Acquisitions | -14,884,000 | -385,000 | -820,000 | -170,000 | -1,332,000 |
| Other Investing Activity | 89,000 | -29,000 | -14,000 | -21,000 | -176,000 |
| Investing Cash Flow | $-17,058,000 | $-3,594,000 | $-3,101,000 | $-2,662,000 | $-1,734,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 149,000 | 1,303,000 | 1,908,000 | 2,690,000 | 2,946,000 |
| Debt Issued | 19,942,000 | 1,994,000 | 2,980,000 | 1,210,000 | 1,000,000 |
| Debt Repayment | -1,268,000 | -565,000 | -2,214,000 | -24,000 | -2,603,000 |
| Common Stock Issued | 649,000 | 1,307,000 | 267,000 | 96,000 | 85,000 |
| Common Stock Repurchased | -1,920,000 | -2,553,000 | -1,247,000 | -1,440,000 | -1,140,000 |
| Dividend Paid | -1,337,000 | -1,116,000 | -1,055,000 | -1,021,000 | -969,000 |
| Other Financing Activity | -266,000 | -1,288,000 | -2,740,000 | -3,393,000 | -1,325,000 |
| Financing Cash Flow | $15,949,000 | $-918,000 | $-2,101,000 | $-1,882,000 | $-2,006,000 |
| Exchange Rate Effect | -353,000 | 37,000 | 7,000 | -71,000 | 62,000 |
| Beginning Cash Position | 1,403,000 | 919,000 | 1,172,000 | 1,317,000 | 1,254,000 |
| End Cash Position | 4,843,000 | 1,403,000 | 919,000 | 1,172,000 | 1,317,000 |
| Net Cash Flow | $3,440,000 | $484,000 | $-253,000 | $-145,000 | $63,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,902,000 | 4,959,000 | 4,942,000 | 4,470,000 | 3,741,000 |
| Capital Expenditure | -571,000 | -396,000 | -457,000 | -484,000 | -501,000 |
| Free Cash Flow | 4,331,000 | 4,563,000 | 4,485,000 | 3,986,000 | 3,240,000 |